Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Daniel N. Johnson
Dihydropyrimidine Dehydrogenase Deficiency as a Cause of Fatal 5-Fluorouracil Toxicity
Autopsy and Case Reports
Related publications
Dihydropyrimidine Dehydrogenase Gene Variation and Severe 5-Fluorouracil Toxicity: A Haplotype Assessment
Pharmacogenomics
Molecular Medicine
Genetics
Pharmacology
Heterozygosity for a Point Mutation in an Invariant Splice Donor Site of Dihydropyrimidine Dehydrogenase and Severe 5-Fluorouracil Related Toxicity
European Journal of Cancer
Cancer Research
Oncology
Novel Deleterious Dihydropyrimidine Dehydrogenase Variants May Contribute to 5-Fluorouracil Sensitivity in an East African Population
Clinical Pharmacology and Therapeutics
Pharmacology
Dihydropyrimidine Dehydrogenase Deficiency: Metabolic Disease or Biochemical Phenotype?
JIMD Reports
Internal Medicine
Genetics
Molecular Biology
Biochemistry
Endocrinology
Metabolism
Diabetes
Capecitabine-Based Treatment of a Patient With a Novel DPYD Genotype and Complete Dihydropyrimidine Dehydrogenase Deficiency
International Journal of Cancer
Cancer Research
Oncology
Correlation Between Thymidylate Synthase and Dihydropyrimidine Dehydrogenase mRNA Level and in Vitro Chemosensitivity to 5-Fluorouracil, in Relation to Differentiation in Gastric Cancer
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
Retroviral Transduction of Human Dihydropyrimidine Dehydrogenase cDNA Confers Resistance to 5-Fluorouracil in Murine Hematopoietic Progenitor Cells and Human CD34+-enriched Peripheral Blood Progenitor Cells
Cancer Gene Therapy
Cancer Research
Molecular Medicine
Molecular Biology
Effects of Oyster Extract on 5-Fluorouracil (5-Fu) Induced Toxicity in Rat
Proceedings for Annual Meeting of The Japanese Pharmacological Society
RNA-Based 5-Fluorouracil Toxicity Requires the Pseudouridylation Activity of Cbf5p
Genetics
Genetics
